EKTA-BElekta AB (publ)
55.25SEK-0.18%Mkt Cap: 2.02B $P/E:

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machin…

Key Statistics

Company
Market Cap2.02B $
Enterprise Value2.40B $
Revenue (TTM)1.60B $
Gross Profit597.73M $
Net Income (TTM)-49.64M $
Revenue/Share4.185 USD
Last Price55.25 SEK
Fiscal Year EndApr 2026
MR QuarterApr 2026
Employees3.6K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINUS28617Y1010
Valuation
P/E (Trailing)
P/E (Forward)11.48
PEG0.28
EV/EBITDA14.87
EV/Revenue1.50
P/S1.27
P/B3.00
EPS (TTM)-1.36
EPS (Forward)4.85
52W Range
41.8654% of range66.70
52W High66.70 SEK
52W Low41.86 SEK
Profitability
Gross Margin37.38%
Oper. Margin10.58%
EBITDA Margin10.09%
Profit Margin-3.10%
ROE-7.31%
ROA-1.93%
Growth
Revenue Growth-7.60%
Earnings Growth
Cash Flow & Leverage
Operating CF235.69M $
CapEx (TTM)102.54M $
FCF Margin7.96%
FCF Yield6.29%
Net Debt396.19M $
Net Debt/EBITDA2.46
Balance Sheet
Debt/Equity1.03
Current Ratio0.87
Quick Ratio0.62
Book Value/Sh18.58 SEK
Cash/Share8.346 SEK
Dividends
Fwd Div Rate2.400 SEK
Trail. Div Rate2.400 SEK
Div. Yield4.48%
5Y Avg Yield3.47%
Payout Ratio315.79%
Ex-Div DateSep 4, 2026
Pay Date
Splits
Last Split4:1
Split DateSep 12, 2012
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)59.96 SEK
Upside (mean)+8.5%
Target Range41.00 SEK100.00 SEK
SEK41.00+8.5% to meanSEK100.00
# Analysts14
Ownership
Shares Out.367.10M
Float311.10M
Insiders1.93%
Institutions67.61%
Technical
SMA 5049.84 (+10.9%)
SMA 20054.22 (+1.9%)
Beta0.97
S&P 52W Chg19.97%
Avg Vol (30d)874.99K
Avg Vol (10d)793.03K
Technical Indicators
RSI (14)72.5
MACD1.3514
MACD Signal0.4873
MACD Hist.+0.8642
BB Upper56.02 SEK
BB Middle50.01 SEK
BB Lower43.99 SEK
BB Width24.05%
ATR (14)1.423 SEK
Vol Ratio (20d)1.57x